|
CEP76 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.118100E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.019600E-01 |
| Normal-vs-Stage2 |
3.522100E-02 |
| Normal-vs-Stage3 |
3.493800E-02 |
| Normal-vs-Stage4 |
2.087800E-02 |
| Stage1-vs-Stage2 |
1.696820E-01 |
| Stage1-vs-Stage3 |
1.791550E-01 |
| Stage1-vs-Stage4 |
1.616980E-01 |
| Stage2-vs-Stage3 |
7.287800E-01 |
| Stage2-vs-Stage4 |
9.704600E-01 |
| Stage3-vs-Stage4 |
7.397800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.071230E-01 |
| Normal-vs-AfricanAmerican |
3.476800E-01 |
| Normal-vs-Asian |
1.801570E-01 |
| Caucasian-vs-AfricanAmerican |
9.194000E-01 |
| Caucasian-vs-Asian |
9.514000E-01 |
| AfricanAmerican-vs-Asian |
8.947800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.396500E-03 |
| Normal-vs-Female |
1.314450E-01 |
| Male-vs-Female |
1.207800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.285400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.615900E-02 |
| Normal-vs-Age(61-80Yrs) |
2.222000E-02 |
| Normal-vs-Age(81-100Yrs) |
6.881600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.212400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.961800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.947380E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.322000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.148400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.291000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.230800E-01 |
| Classical-VS-Follicular |
3.5830000000292E-06 |
| Classical-VS-Other |
4.117000E-01 |
| Classical-VS-Normal |
4.423000E-01 |
| Tall-VS-Follicular |
2.260300E-02 |
| Tall-VS-Other |
5.690000E-01 |
| Tall-VS-Normal |
3.247600E-01 |
| Follicular-VS-Other |
5.088600E-01 |
| Follicular-VS-Normal |
1.627390E-04 |
| Other-VS-Normal |
2.799400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.393600E-02 |
| Normal-vs-N1 |
6.724400E-02 |
| N0-vs-N1 |
8.614600E-01 |
|
|
